TYMIANSKI MICHAEL has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CAN FITE BIOPHARMA LTD, ZENSUN SHANGHAI SCIENCE & TECHNOLOGY LTD and IMMEDICA PHARMA AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Tymianski Michael | 12 |
#2 | Garman Jonathan David | 4 |
#3 | Lu Peter S | 1 |
#4 | Cui Hong | 1 |
Publication | Filing date | Title |
---|---|---|
US2012252731A1 | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory | |
US2009176713A1 | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory | |
US2012208764A1 | Method and compositions for treating stroke with fever | |
US7595297B2 | Method of reducing injury to mammalian cells | |
CA2273622A1 | Inhibition of nmda receptor signalling in reducing neuronal damage |